Loading...

Stable Dry Powder Formulation for Nasal Delivery of Anthrax Vaccine

There is a current biodefense interest in protection against Anthrax. Here we developed a new generation of stable and effective anthrax vaccine. We studied the immune response elicited by rPA delivered intranasally with a novel mucosal adjuvant, a mast cell activator Compound 48/80. The vaccine for...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Wang, Sheena H., Kirwan, Shaun M., Abraham, Soman N., Staats, Herman F., Hickey, Anthony J.
Format: Artigo
Sprog:Inglês
Udgivet: 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3725471/
https://ncbi.nlm.nih.gov/pubmed/21905034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.22742
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!